Form 4: Axogen CMO Jens Kemp Reports Routine Stock Transactions

Axogen's Chief Marketing Officer, Jens Kemp, reported the vesting of performance-based stock units and the grant of new restricted stock units, alongside tax-related share withholdings.

Summary

• Jens Kemp, Chief Marketing Officer of Axogen, Inc. (AXGN), reported several stock transactions.
• 50,670 shares of Common Stock vested on February 26, 2026, due to the attainment and certification of certain performance criteria.
• Beneficial ownership was corrected, noting a previous overstatement of 4,003 shares.
• An additional 2,120 shares were acquired under the Axogen Employee Stock Purchase Plan on December 31, 2025.
• 15,414 shares of Common Stock were withheld by the issuer on February 26, 2026, at a price of $31.9 per share, to cover tax liabilities from the vesting of performance stock units (PSUs).
• An additional 2,952 shares of Common Stock were withheld by the issuer on March 1, 2026, at a price of $30.65 per share, to cover tax liabilities from the vesting of restricted stock units (RSUs).
• Kemp was granted 23,000 Restricted Stock Units (RSUs) on February 26, 2026.
• Following these transactions, Kemp beneficially owns 76,451 shares of Common Stock and 23,000 Restricted Stock Units.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as slightly positive, primarily due to the vesting of performance-based awards, indicating achievement of company goals, and the grant of new equity incentives, which aligns executive interests with long-term shareholder value, despite routine tax-related share withholdings.

Positives

• The vesting of 50,670 performance stock units indicates the achievement and certification of certain performance criteria.
• The grant of 23,000 new Restricted Stock Units aligns executive incentives with long-term company performance.
• The acquisition of 2,120 shares through the Employee Stock Purchase Plan demonstrates continued insider investment.

Negatives

• A total of 18,366 shares (15,414 from PSUs and 2,952 from RSUs) were withheld by the issuer to cover tax liabilities, reducing direct beneficial ownership.
• A previous Form 4 overstated beneficial ownership by 4,003 shares, requiring a correction in this filing.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for executive stock transactions, reflecting routine compensation events such as the vesting of performance awards and the grant of new equity incentives. These transactions are common across publicly traded companies as a mechanism for aligning executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The vesting of performance shares suggests management achieved certain goals, potentially benefiting shareholders. The grant of new RSUs aligns executive incentives with long-term shareholder value.
• Employees: The mention of the Employee Stock Purchase Plan (ESPP) indicates a program available to employees, fostering broader employee ownership.

Next Steps

• Delivery of vested shares to the reporting person upon future vesting dates (February 26, 2028, February 26, 2029, February 26, 2030).

Key Dates

Recommendation

This Form 4 details routine executive compensation events, including the vesting of performance awards and the grant of new restricted stock units, along with standard tax-related share withholdings. Such transactions are typical and do not provide new fundamental information that would warrant a change in investment recommendation for Axogen, Inc. The achievement of performance criteria for vested shares is a positive, but the overall impact on the company's valuation or strategic direction is neutral.

Keywords

Axogen, AXGN, Jens Kemp, Chief Marketing Officer, Form 4, insider transaction, executive compensation, stock vesting, RSU, PSU, employee stock purchase plan, beneficial ownership